共 18 条
[1]
Porter D.R., Capell H.A., The use of sulphasalazine as a disease modifying drug, Baillieres Clin Rheumatol, 4, pp. 535-541, (1990)
[2]
Farr M., Scott D.G., Bacon P.A., Side effect profile of 200 patients with inflammatory arthritides treated with sulphasalazine, Drugs, 32, pp. 49-53, (1986)
[3]
Amos R.S., Pullar T., Bax D.E., Situnayake D., Capell H.A., McConkey B., Sulphasalazine for rheumatoid arthritis: toxicity in 774 patients monitored for one to 11 years, Br Med J Clin Res, 293, pp. 420-423, (1986)
[4]
Donovan S., Hawley S., MacCarthy J., Scott D.L., Tolerability of enteric coated sulphasalazine in rheumatoid arthritis: results of a cooperating clinics study, Br J Rheumatol, 29, pp. 201-204, (1990)
[5]
Haines J.D., Hepatotoxicity after treatment with sulphasalazine, Postgrad Med, 79, pp. 193-198, (1986)
[6]
Ribe J., Benkov K.J., Thung S.N., Shen S.C., LeLeiko N.S., Fatal massive hepatic necrosis: a probable hypersensitivity reaction to sulphasalazine, Am J Gastroenterol, 81, pp. 205-208, (1986)
[7]
Kojis F.J., Serum sickness and anaphylaxis: analysis of cases of 6,211 patients treated with horse serum for various infections, American Journal of Diseases of Children, 64, pp. 93-143, (1942)
[8]
Hunt L.W., Recent observations in serum disease, Journal of the American Medical Association, 99, pp. 909-912, (1932)
[9]
Germuth F.C., A comparative histologic and immunologic study in rabbits of induced hypersensitivity of the serum sickness type, Journal of Experimental Medicine, 97, pp. 257-282, (1953)
[10]
Dixon F.J., Feldman J.D., Vasquez J.J., Experimental glomerulonephritis: the pathogenesis of a laboratory model resembling the spectrum of human glomerulonephritis, Journal of Experimental Medicine, 113, pp. 899-920, (1961)

